期刊文献+

帕金森病人血清胱抑素C水平、尿酸变化与病情分期、认知障碍、运动功能的相关性研究 被引量:7

Correlation study of serum cystatin C level,uric acid change with disease stage,cognitive impairment,motor function in Parkinson′s disease patients
在线阅读 下载PDF
导出
摘要 目的:探讨帕金森病(PD)病人血清胱抑素C(CysC)、尿酸(UA)水平变化与病情分期、认知障碍、运动功能的相关性。方法:纳入PD病人90例作为PD组,选取同期健康体检者82名作为健康组。比较2组血清CysC与UA水平,根据帕金森Hoehn-Yahr(H-Y)分期将PD病人分成H-Y≥3期组(n=36)、H-Y<3期组(n=54)。根据蒙特利尔认知评估量表(MoCA)将PD病人分成认知障碍组(n=49,MoCA<26分)、非认知障碍组(n=41,MoCA≥26分)。根据统一帕金森病评估量表第三部分(UPDRS-Ⅲ)评估PD病人运动障碍程度,并分成轻度组(n=26,0~15分)、中度组(n=41,16~40分)、重度组(n=23,41~56分)。比较不同病情分期、认知障碍、运动功能病人的血清CysC与UA水平,经Pearson线性相关分析血清CysC、UA水平与H-Y分期、MoCA评分、UPDRS-Ⅲ评分的相关性。结果:PD组血清CysC高于健康组,但血清UA水平低于健康组(P<0.01)。H-Y≥3期组血清CysC、H-Y分期较H-Y<3期组增高,血清UA较H-Y<3期组降低(P<0.01)。认知障碍组血清CysC较非认知障碍组增高,血清UA、MoCA评分较非认知障碍组降低(P<0.01)。重度组血清CysC及UPDRS-Ⅲ评分较中、轻度组增高,且中度组高于轻度组,但重度组血清UA较中、轻度组降低,且中度组低于轻度组(P<0.01)。Pearson线性相关分析结果显示,PD病人血清CysC与H-Y分期、UPDRS-Ⅲ评分呈正相关,与MoCA评分呈负相关(P<0.05~P<0.01),而血清UA与H-Y分期、UPDRS-Ⅲ评分呈负相关,与MoCA评分呈正相关(P<0.05~P<0.01)。结论:PD病人血清CysC水平增高,而血清UA降低,且二者均与病人的病情分期、认知障碍、运动功能存在相关性,临床可将血清CysC、UA作为评估PD进展的指标。 Objective:To explore the relationship between the changes in serum cystatin C(CysC) and uric acid(UA) in Parkinson′s disease(PD) patients with disease stage,cognitive impairment,and motor function.Methods:A total of 90 PD patients were selected as the PD group,and 82 healthy people who received physical examination during the same period were selected as the healthy group.Levels of serum CysC and UA were compared between the two groups.PD patients were divided into H-Y≥3 stage group(n=36) and H-Y<3 stage group(n=54) according to Parkinson′s Hoehn-Yahr(H-Y) staging.According to the Montreal cognitive assessment scale(MoCA),PD patients were divided into cognitive impairment group(n=49,MoCA<26 points) and non-cognitive impairment group(n=41,MoCA≥26 points).According to the third part of the unified parkinson′s disease assessment scale(UPDRS-Ⅲ),the degree of dyskinesia of PD patients was evaluated,and they were divided into the mild group(n=26,0-15 points),moderate group(n=41,16-40 Points),and severe group(n=23,41-56 points).The serum CysC and UA in patients with different disease stages,cognitive impairment,and motor function were compared.The correlation among the serum CysC and UA levels,H-Y staging,MoCA score and UPDRS-Ⅲ score was analyzed by Pearson linear correlation.Results:The serum CysC in PD group was higher than that in healthy group,but the level of serum UA was lower than that in healthy group(P<0.01).Serum CysC and H-Y staging of H-Y≥3 stage group were higher than H-Y<3 stage group,and serum UA was lower than H-Y<3 stage group(P<0.01).The serum CysC of the cognitive impairment group was higher than that in the non-cognitive impairment group,and the serum UA and MoCA score were lower than that in the non-cognitive impairment group(P<0.01).Serum CysC and UPDRS-Ⅲ scores of the severe group were higher than those in the moderate and mild groups,and the moderate group was higher than the mild group,but the severe group had a lower serum UA than the moderate and mild groups,and the moderate group was lower than the mild group(P<0.01).The results of Pearson linear correlation analysis showed that serum CysC in PD patients was positively correlated with HY staging and UPDRS-Ⅲ score,and negatively correlated with MoCA score(P<0.05 to P<0.01),while serum UA was negatively correlated with HY staging and UPDRS-Ⅲ score,and positively correlated with MoCA score(P<0.05 to P<0.01).Conclusions:Serum CysC level in PD patients is increased,while serum UA is decreased,and both of them are related to the patient′s disease stage,cognitive impairment and motor function.Serum CysC and UA can be used clinically as indicators to evaluate the PD progression.
作者 马婷婷 胡鸿炜 林慧怡 张应魏 MA Ting-ting;HU Hong-wei;LIN Hui-yi;ZHANG Ying-wei(Department of Internal Medicine,Cadre Sanatorium of Hainan&Geriatric Hospital of Hainan,Haikou Hainan 571100,China;Department of Neurolgy,Cadre Sanatorium of Hainan&Geriatric Hospital of Hainan,Haikou Hainan 571100,China)
出处 《蚌埠医学院学报》 CAS 2022年第8期1043-1047,共5页 Journal of Bengbu Medical College
关键词 帕金森病 胱抑素C 尿酸 Hoehn-Yahr分期 运动功能 认知障碍 Parkinson′s disease cystatin C uric acid Hoehn-Yahr staging motor function cognitive impairment
作者简介 马婷婷(1986-),女,主治医师.
  • 相关文献

参考文献14

二级参考文献98

  • 1韦春英,韩敏,莫颖敏,罗文静,刘波.普拉克索对帕金森病患者轻度认知功能障碍的影响[J].医学信息,2017,30(3):32-33. 被引量:6
  • 2龚守会,陈全凤,朱贵忠,张贵斌,宋金辉,罗韵文.帕金森病患者血尿酸水平的检测及其临床意义[J].中国全科医学,2009,12(7):595-596. 被引量:6
  • 3张萍,张留莎,王传升.阿尔茨海默病和帕金森痴呆患者脑脊液中tau蛋白和β淀粉样蛋白水平的研究[J].中华老年心脑血管病杂志,2007,9(2):113-115. 被引量:6
  • 4Tizon B, Sahoo S, Yu H, et al. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines [ J ]. PLoS ONE, 2010, 5 : 1 - 12.
  • 5Ucibior A, Golebiowska D, Adamczyk A, et al. The renal effects of vanadate exposure: potential biomarkers and oxidative stress as a mechanism of functional renal disorders--preliminary studies [ J ]. Biomed Res Int, 2014, 2014:7401 - 7405.
  • 6Gauthier SA, Tizon B, Sahoo S, et al. In vitro assays measuring protection by proteins such as cystatin C of primary cortical neuronal and smooth muscle cells[J]. Methods Mol Biol, 2012, 849:275 - 287.
  • 7Wilson ME, Boumaza I, Bowser R. Measurement of cystatin C func- tional activity in the cerebrospinal fluid of amyotrophic lateral scle- rosis and control subjects[J]. Fluids Barriers CNS, 2013, 10:10 -15.
  • 8Bobek I, Levine MJ. Cystatins ?? Inhibitors of Cysteine Proteina- ses[J]. Crit Rev Oral Biol Med, 1992, 3:307 -332.
  • 9Janowski R, Kozak M, Jankowska E, et al. Human cystatin C, an amyloidogenic protein, dimer/zes through three-dimensional domain swapping[J]. Nat Struct Biol, 2001, 8:316-320.
  • 10Yamada T, Mukaiyama I, Miyake N, et al. Measurement of cystatin C in cerebrospinal fluid[J]. Rinsho Byori, 2002, 50:613-617.

共引文献101

同被引文献83

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部